Graft-Versus-Host Disease Clinical Trials in Shanghai, Shanghai Municipality
3 recruitingShanghai, Shanghai Municipality, China
Showing 1–3 of 3 trials
Recruiting
Phase 3
Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination With Post-engraftment Anti-thymoglobin as Graft Versus Host Disease Prophylaxis in Alternative Donor Peripheral Stem Cell Transplantation
Allogeneic Hematopoietic Cell TransplantGraft-Versus-Host Disease
Shanghai Jiao Tong University School of Medicine316 enrolled1 locationNCT06705062
Recruiting
Phase 3
Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease
Graft-Versus-Host Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.182 enrolled41 locationsNCT06682169
Recruiting
Not Applicable
Prospective Clinical Trial for Children With TCRαβ Depleted vs Traditional Haplo Identicle HSCT
Child, OnlyHaploidentical Hematopoietic Stem Cell TransplantationGraft-Versus-Host Disease+1 more
Sijia Gu110 enrolled1 locationNCT06423131